Alex Carchidi
TMFacarchidi
Alex began writing for the Fool in early 2020 and follows companies in the healthcare sector. Formerly a researcher in the biotech industry, he leverages his science background in his work as a writer and entrepreneur. His interests include exploring his hometown of Boston, traveling in Latin America, and value investing.
Recent Articles by Alex Carchidi

Mar 26, 2025
by Alex Carchidi
This 1 Overlooked Metric Could Send Solana to $500

Mar 20, 2025
by Alex Carchidi
Should You Buy XRP With $1,000, or Cardano?

Mar 20, 2025
by Alex Carchidi
Is This One Catalyst for XRP a Sell-the-News Event?

Mar 20, 2025
by Alex Carchidi
What Are the Chances That XRP Climbs to $100?

Mar 20, 2025
by Alex Carchidi
2 New Signs That XRP Is on Its Way to $3 and Beyond
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.